Comerica Bank Raises Stock Position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Comerica Bank boosted its position in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 23.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,466 shares of the company’s stock after acquiring an additional 462 shares during the period. Comerica Bank’s holdings in iShares U.S. Pharmaceuticals ETF were worth $162,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Atala Financial Inc purchased a new position in iShares U.S. Pharmaceuticals ETF in the 4th quarter worth approximately $25,000. Union Bancaire Privee UBP SA purchased a new position in iShares U.S. Pharmaceuticals ETF in the 4th quarter worth approximately $42,000. Capital Analysts LLC grew its stake in iShares U.S. Pharmaceuticals ETF by 41.8% in the 4th quarter. Capital Analysts LLC now owns 1,575 shares of the company’s stock worth $104,000 after buying an additional 464 shares in the last quarter. Runnymede Capital Advisors Inc. purchased a new position in iShares U.S. Pharmaceuticals ETF in the 4th quarter worth approximately $164,000. Finally, Sequoia Financial Advisors LLC grew its stake in iShares U.S. Pharmaceuticals ETF by 19.1% in the 4th quarter. Sequoia Financial Advisors LLC now owns 3,433 shares of the company’s stock worth $226,000 after buying an additional 550 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Price Performance

IHE stock opened at $64.83 on Friday. iShares U.S. Pharmaceuticals ETF has a one year low of $58.97 and a one year high of $73.28. The stock has a market cap of $557.54 million, a PE ratio of 23.46 and a beta of 0.63. The firm has a 50 day simple moving average of $66.01 and a two-hundred day simple moving average of $67.69.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.